Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MCS Formulas is a nutraceutical company specializing in high-bioavailability dietary supplements designed to support patients with chronic conditions, particularly cancer. Founded by individuals inspired by the "My Cancer Story" movement, the company focuses on providing evidence-based, high-purity formulations of natural compounds like curcumin, quercetin, and berberine. Their products often utilize advanced delivery technologies, such as liposomal encapsulation and phytosomes, to enhance absorption and therapeutic efficacy. MCS Formulas operates primarily in the European market, catering to the integrative oncology community and health-conscious consumers seeking pharmaceutical-grade natural products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MCS Formulas.